Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. (Q46787342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

adenoid cystic carcinoma

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ching-Hung Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ruoh-Fang Yen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yung-Ming Jeng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Chin-Yuan Tzen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chiun Hsu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1022-1027

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16265655%20AND%20SRC:MED&resulttype=core&format=json

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group

8 January 2020

cites work

1 reference

Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases

21 January 2018

1 reference

7 January 2021

Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck

1 reference

7 January 2021

Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma

1 reference

7 January 2021

C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma

1 reference

7 January 2021

C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma

1 reference

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

7 January 2021

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

7 January 2021

HER2/neu expression in adenoid cystic carcinoma of salivary gland origin: an immunohistochemical study

1 reference

7 January 2021

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

7 January 2021

Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands

1 reference

7 January 2021

Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases

1 reference

7 January 2021

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

1 reference

7 January 2021

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

7 January 2021

Imatinib mesylate: in the treatment of gastrointestinal stromal tumours

1 reference

7 January 2021

c-Abl: activation and nuclear targets

1 reference

7 January 2021

Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype

1 reference

7 January 2021

Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site

1 reference

7 January 2021

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

1 reference

7 January 2021

Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivo

1 reference

7 January 2021